Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Current Assets (2022 - 2025)

NewGenIvf (NIVF) has disclosed Current Assets for 4 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 132.72% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, up 132.72% year-over-year, with the annual reading at $7.4 million for FY2025, 132.72% up from the prior year.
  • Current Assets for Q4 2025 was $7.4 million at NewGenIvf, up from $3.2 million in the prior quarter.
  • The five-year high for Current Assets was $7.4 million in Q4 2025, with the low at $2.4 million in Q4 2022.
  • Average Current Assets over 4 years is $3.9 million, with a median of $2.8 million recorded in 2023.
  • The sharpest move saw Current Assets increased 2.51% in 2023, then soared 132.72% in 2025.
  • Over 4 years, Current Assets stood at $2.4 million in 2022, then rose by 2.51% to $2.5 million in 2023, then grew by 29.03% to $3.2 million in 2024, then surged by 132.72% to $7.4 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $7.4 million, $3.2 million, and $2.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.